Menopur

Menopur®

Powder and solvent for solution for injection

Human menopausal gonadotrophin

Consumer Medicine Information

NOTICE: This Consumer Medicine Information (CMI) is intended for persons
living in Australia. This page contains answers to some common
questions about Menopur. It does
not contain all the information that is known about
Menopur. It does not take the
place of talking to your doctor or pharmacist. All medicines have risks
and benefits. Your doctor has weighed the risk of you using this medicine
against the benefits he/she expects it will have for you. If you have
any concerns about using this medicine, ask your doctor or pharmacist.
Bookmark or print this page, you may need to read it again.

What Menopur is used for

Menopur contains highly purified human menopausal gonadotrophin (hMG), also known as menotrophin, as the active ingredient.
It is obtained from the urine of post-menopausal women.

hMG is a mixture of three hormones with follicle stimulating hormone (FSH) activity and luteinising hormone (LH) activity
found naturally in humans.

Menopur belongs to a class of medicines called gonadotrophins.

Menopur is used to treat infertility (reproduction related conditions) in women.

Menopur is used in women who are not ovulating (not producing eggs). It helps women become pregnant by stimulating the ovarian
follicles to release an egg.

Menopur is also used to stimulate the ovarian follicles in women undergoing Assisted Reproductive Technology (ART) such as
IVF/EF (in vitro fertilisation/embryo transfer) to help them become pregnant.

Your doctor will be able to talk to you about your specific fertility problem.

Menopur is given only by or under the supervision of your doctor.

Ask your doctor if you have any questions about why this medicine has been prescribed for you.

Your doctor may have prescribed it for another reason.

This medicine is not addictive.

This medicine is available only with a doctor's prescription.

This medicine is not expected to affect your ability to drive a car or operate machinery.

Before you use Menopur

The active ingredient in this preparation is extracted from human urine. Therefore, the risk of transmission of a pathogen
(known or unknown) cannot be completely excluded.

When you must not use it

Do not use Menopur if you have or have had an allergy to:

any medicine containing menotrophin or human menopausal gonadotrophin

any of the ingredients listed at the end of this leaflet.

Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of
the face, lips, tongue or other parts of the body; rash, itching or hives on the skin.

Do not use Menopur if:

you have tumours of the uterus (womb), ovaries, breasts, pituitary gland or hypothalamus

you have cysts on your ovaries or enlarged ovaries (unless caused by polycystic ovarian disease)

you have any physical defects of the uterus (womb) or other sexual organs

you suffer from bleeding from the vagina where the cause is not known

you have fibroids of the uterus (womb)

you are pregnant

you are breastfeeding.

Do not use Menopur after the expiry date printed on the pack.

Do not use Menopur if the packaging is torn or shows signs of tampering.

If you are not sure whether you should have this medicine, talk to your doctor.

Before you use it

Tell your doctor if you have allergies to:

any other medicines

any other substances such as foods, preservatives or dyes.

Tell your doctor if you have or have had any medical conditions, especially the following:

problems with genital organs

adrenal problems

thyroid problems

diabetes, or a family history of diabetes

primary ovarian failure

polycystic ovarian syndrome (PCOS)

ovarian hyperstimulation syndrome (OHSS)

any problems with your liver, kidneys or other organs.

If you have not told your doctor about any of the above, tell him/her before you are given Menopur.

Taking other medicines

Tell your doctor if you are taking any other medicines, including any that you get without a prescription from your pharmacy,
supermarket or health food shop.

If Menopur is used at the same time as clomiphene citrate the effect on the ovaries may be increased.

How Menopur is used

How it is used

Menopur is given as an injection under the skin (subcutaneous), usually near the stomach.

If your doctor or nurse decides you can give the injections yourself, they will teach you the injection technique.

Do not self-inject until you are sure of how to do it.

Follow all instructions given to you by your doctor carefully.

Please see the leaflet supplied with Menopur for detailed instructions on how it is to be reconstituted and administered.

How much is used

The dose of Menopur will depend on your condition and will be determined by your doctor.

Women who are not ovulating, (not producing eggs):

Treatment should start within the first 7 days of the menstrual cycle (day 1 is the first day of your period). Treatment should
be given every day for at least 7 days.

The starting dose is normally 75-150 IU daily. This dose may be increased according to your response to the treatment up to
maximum of 225 IU per day. A particular dose should be given for at least 7 days before the dose is changed. The cycle of
treatment should be abandoned if there is no response after 4 weeks.

When a good response is obtained a single injection of another hormone called human chorionic gonadotrophin (hCG), should
be given 1 day following the last Menopur injection. It is recommended that you have sexual intercourse on the day of the
hCG injection and the day after. Alternatively, artificial insemination (injection of sperm directly into the womb) may be
performed. Your doctor will closely monitor your progress for at least 2 weeks after you have received the hCG injection.

Your doctor will monitor the effect of Menopur treatment. Depending on your progress, your doctor may decide to stop treatment
with Menopur and not give you the hCG injection. In this case, you will be instructed to use a barrier method of contraception
(e.g. condom) or not have sexual intercourse until your next period has started.

Women undergoing Assisted Reproductive Technology (ART):

If you are also receiving treatment with a GnRH agonist (a medicine that acts like a hormone called Gonadotrophin Releasing
Hormone, GnRH), Menopur should be started approximately 2 weeks after the start of the GnRH agonist therapy.

In patients receiving a GnRH antagonist, Menopur treatment should be started on day 2 or 3 of the menstrual cycle (day 1 is
the first day of your period).

Treatment should be given every day for at least 5 days. The initial dose of Menopur is normally 150-225 IU. This dose may
be increased according to your response to the treatment up to a maximum of 450 IU per day. Normally treatment should not
continue for more than 20 days.

If enough egg sacs are present, you will be given a single injection of a medicine called human chorionic gonadotrophin (hCG)
to induce ovulation (release of an egg).

Your doctor will closely monitor your progress for at least 2 weeks after you have received the hCG injection.

Your doctor will monitor the effect of Menopur treatment. Depending on your progress, your doctor may decide to stop treatment
with Menopur and not give you the hCG injection. In this case, you will be instructed to use a barrier method of contraception
(e.g. condom) or not have sexual intercourse until your next period has started.

How often is it given

The length of treatment varies with each patient being treated. Your doctor will be able to answer this question.

It is possible to have more than one treatment cycle of Menopur.

Overdose

As Menopur is given to you under the supervision of your doctor, it is very unlikely that you will receive too much.

In women, hyperstimulation of the ovaries, known as ovarian hyperstimulation syndrome (OHSS) is a rare but potentially serious
complication of infertility therapy and can be the result of excessive doses of Menopur. Without proper hospital management
this condition may even be fatal.

Tell your doctor straight away, even if the symptoms develop some days after the last injection has been given. This can be
a sign of high levels of activity in the ovaries. Therefore symptoms might become severe.

If these symptoms become severe, the infertility treatment should be stopped and you should receive treatment in hospital.

Keeping to your recommended dose and careful monitoring of your treatment will reduce your chances of getting these symptoms.

Things you must do

Tell your doctor immediately if you become pregnant while having Menopur.

Tell your doctor if you have abnormal vaginal bleeding while having Menopur.

Be sure to keep all your doctor's appointments so your progress can be checked.

Your doctor will normally arrange for you to have ultrasound scans and do some blood and other tests from time to time to
check on your progress and detect any unwanted side effects.

Tell any other doctors, dentists, and pharmacists who are treating you that you are taking Menopur.

If you are about to be started on any new medicine, tell your doctor, dentist or pharmacist that you are taking Menopur.

If you are going to have surgery, tell the surgeon or anaesthetist that you are taking Menopur.

Things to be careful of

Menopur should not normally interfere with your ability to drive or operate machinery.

Side effects

Tell your doctor or nurse or pharmacist as soon as possible if you do not feel well after you have Menopur.

This medicine helps most people with infertility, but it may have unwanted side effects in a few people. All medicines can
have side effects. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some
of the side effects.

Do not be alarmed by the following lists of side effects. You may not experience any of them.

Ask your doctor or nurse or pharmacist to answer any questions you may have.

Tell your doctor if you notice any of the following and they worry you:

local reaction around the injection site such as redness, itchiness, tenderness, pain or discomfort, warmth, burning or stinging
or swelling

Menopur sometimes stimulates the ovaries too much. This is called ovarian hyperstimulation syndrome (OHSS) and can be a serious
medical problem. OHSS may cause pelvic pain or breathing problems. It may also make you urinate less. In rare cases, patients
with this problem have had serious lung problems. This includes fluid in the lungs, trouble breathing, and worsening of asthma

blood clots and strokes.

These are very serious side effects. You may need urgent medical attention or hospitalisation.

Tell your doctor or pharmacist if you notice anything that is making you feel unwell.

Other side effects not listed above may also occur in some people.

After using Menopur

Storage

Keep Menopur where children cannot reach it.

Keep Menopur in the original pack until it is time for it to be used.

Store Menopur 600 IU and 1200 IU in a refrigerator (2 to 8°C). Do not freeze. After reconstitution, the solution may be stored
for up to 28 days.

Disposal

If you are self-injecting, you should discard all sharps into a disposal unit.

If you have any Menopur that has expired or is left over from your treatment refer this to your clinic.

Product description

What it looks like

Menopur 600 IU

The product is supplied as a pack containing one vial of powder, one pre-filled syringe with solvent for reconstitution and
one needle for reconstitution. Disposable alcohol pads and single-use administration syringes (graduated in FSH/LH units with
pre-fixed needles) are supplied separately.

Menopur 1200 IU

The product is supplied as a pack containing one vial of powder, two pre-filled syringes with solvent for reconstitution and
one needle for reconstitution. Disposable alcohol pads and single-use administration syringes (graduated in FSH/LH units with
pre-fixed needles) are supplied separately.

News-Medical.Net provides this medical information service in accordance
with these terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.